Cargando…
A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies
Enhancement or inhibition of cytokine signaling and corresponding immune cells responses are critical factors in various disease treatments. Cytokine signaling may be inhibited by cytokine-neutralizing antibodies (CNAs), which prevents further activation of cytokine receptors. However, CNAs may resu...
Autores principales: | Shulgin, Boris, Helmlinger, Gabriel, Kosinsky, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752257/ https://www.ncbi.nlm.nih.gov/pubmed/26870966 http://dx.doi.org/10.1371/journal.pone.0149154 |
Ejemplares similares
-
Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis
por: Shulgin, Boris, et al.
Publicado: (2020) -
Role of T Cell-To-Dendritic Cell Chemoattraction in T Cell Priming Initiation in the Lymph Node: An Agent-Based Modeling Study
por: Azarov, Ivan, et al.
Publicado: (2019) -
Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology
por: Peskov, Kirill, et al.
Publicado: (2019) -
Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems model
por: Kosinsky, Yuri, et al.
Publicado: (2018) -
Unexpected mechanisms of action for a cytokine receptor-blocking antibody
por: Hercus, Timothy R, et al.
Publicado: (2014)